CAFs activated by oral cancer-derived EVs revealed upregulation of the pro-inflammatory gene IL-6, not seen in CAFs activated by TGFβ (Supplementary Table S1) and iCAFs are known to secrete IL-6 (Biffi et al., 2019). The gene discussed is IL6; the disease is lip and oral cavity carcinoma.